BRPI0607811A2 - derivados de óxido de pirimidina de 2-(4-cianofenilamino) inibidores de hiv, composição farmacêutica compreendendo os mesmo, processo para preparar a referida composição e uso - Google Patents
derivados de óxido de pirimidina de 2-(4-cianofenilamino) inibidores de hiv, composição farmacêutica compreendendo os mesmo, processo para preparar a referida composição e usoInfo
- Publication number
- BRPI0607811A2 BRPI0607811A2 BRPI0607811-7A BRPI0607811A BRPI0607811A2 BR PI0607811 A2 BRPI0607811 A2 BR PI0607811A2 BR PI0607811 A BRPI0607811 A BR PI0607811A BR PI0607811 A2 BRPI0607811 A2 BR PI0607811A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- preparing
- oxide derivatives
- cyanophenylamino
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05101270.6 | 2005-02-18 | ||
EP05101270 | 2005-02-18 | ||
PCT/EP2006/060115 WO2006087387A1 (en) | 2005-02-18 | 2006-02-20 | Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0607811A2 true BRPI0607811A2 (pt) | 2009-10-06 |
BRPI0607811B1 BRPI0607811B1 (pt) | 2019-08-20 |
BRPI0607811B8 BRPI0607811B8 (pt) | 2021-05-25 |
Family
ID=36570887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0607811A BRPI0607811B8 (pt) | 2005-02-18 | 2006-02-20 | derivados de óxido de pirimidina de 2-(4-cianofenilamino) inibidores de hiv, composição farmacêutica compreendendo os mesmos, processo para preparar a referida composição e uso |
Country Status (10)
Country | Link |
---|---|
US (1) | US7935711B2 (pt) |
EP (1) | EP1853567B1 (pt) |
JP (1) | JP5247154B2 (pt) |
CN (1) | CN101119976B (pt) |
AU (1) | AU2006215599B2 (pt) |
BR (1) | BRPI0607811B8 (pt) |
ES (1) | ES2533258T3 (pt) |
MX (1) | MX2007010051A (pt) |
RU (1) | RU2398768C2 (pt) |
WO (1) | WO2006087387A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2469032C2 (ru) | 2006-12-13 | 2012-12-10 | Ф.Хоффманн-Ля Рош Аг | Производные 2-(пиперидин-4-ил)-4-фенокси- или фениламинопиримидина в качестве ненуклеозидных ингибиторов обратной транскриптазы |
EP2342186B1 (en) * | 2009-06-22 | 2014-09-17 | Emcure Pharmaceuticals Limited | Process for synthesis of etravirine |
US8153790B2 (en) | 2009-07-27 | 2012-04-10 | Krizmanic Irena | Process for the preparation and purification of etravirine and intermediates thereof |
WO2011019943A1 (en) * | 2009-08-12 | 2011-02-17 | Poniard Pharmaceuticals, Inc. | Method of promoting apoptosis and inhibiting metastasis |
CA2803848A1 (en) * | 2010-06-28 | 2012-01-05 | Hetero Research Foundation | A process for etravirine intermediate and polymorphs of etravirine |
WO2012006081A1 (en) | 2010-06-29 | 2012-01-12 | Poniard Pharmaceuticals, Inc. | Oral formulation of kinase inhibitors |
WO2012012139A1 (en) | 2010-06-30 | 2012-01-26 | Poniard Pharmaceuticals, Inc. | Synthesis and use of kinase inhibitors |
US9126949B2 (en) | 2011-04-25 | 2015-09-08 | Hetero Research Foundation | Process for rilpivirine |
PL2702045T3 (pl) * | 2011-04-26 | 2018-04-30 | Mylan Laboratories Ltd. | Nowy sposób sporządzania Etrawiryny |
WO2021167495A1 (en) | 2020-02-19 | 2021-08-26 | Pharmasyntez, Joint Stock Company | Pyrimidine-based bicycles as antiviral agents for the treatment and prevention of hiv infection |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU230394B1 (hu) * | 1998-11-10 | 2016-04-28 | Janssen Pharmaceutica N.V. | HIV-vírus szaporodását gátló pirimidin-származékok |
AU775360B2 (en) * | 1999-09-24 | 2004-07-29 | Janssen Pharmaceutica N.V. | Antiviral compositions |
AR039540A1 (es) * | 2002-05-13 | 2005-02-23 | Tibotec Pharm Ltd | Compuestos microbicidas con contenido de pirimidina o triazina |
TW200409629A (en) | 2002-06-27 | 2004-06-16 | Bristol Myers Squibb Co | 2,4-disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors |
MX2007003796A (es) | 2004-09-30 | 2007-04-25 | Tibotec Pharm Ltd | Pirimidinas 5-sustituidas inhibidoras del virus de inmunodeficiencia humana. |
CA2577467C (en) | 2004-09-30 | 2013-05-28 | Tibotec Pharmaceuticals Ltd. | Hiv inhibiting 5-heterocyclyl pyrimidines |
CN101107234B (zh) | 2005-01-27 | 2013-06-19 | 泰博特克药品有限公司 | 抑制hiv的2-(4-氰基苯氨基)嘧啶衍生物 |
AU2006222057B2 (en) | 2005-03-04 | 2012-10-04 | Janssen Sciences Ireland Uc | HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
RU2480464C2 (ru) | 2006-03-30 | 2013-04-27 | Тиботек Фармасьютикалз Лтд. | 5-амидо-замещенные пиримидины, ингибирующие вич |
EP2004641B1 (en) | 2006-03-30 | 2010-09-29 | Tibotec Pharmaceuticals | Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
JP5185283B2 (ja) | 2006-12-29 | 2013-04-17 | テイボテク・フアーマシユーチカルズ | Hiv阻害6−置換ピリミジン |
-
2006
- 2006-02-20 CN CN2006800053322A patent/CN101119976B/zh not_active Expired - Fee Related
- 2006-02-20 AU AU2006215599A patent/AU2006215599B2/en not_active Ceased
- 2006-02-20 US US11/814,958 patent/US7935711B2/en active Active
- 2006-02-20 BR BRPI0607811A patent/BRPI0607811B8/pt not_active IP Right Cessation
- 2006-02-20 EP EP06743193.2A patent/EP1853567B1/en active Active
- 2006-02-20 JP JP2007555635A patent/JP5247154B2/ja active Active
- 2006-02-20 RU RU2007134564/04A patent/RU2398768C2/ru active
- 2006-02-20 WO PCT/EP2006/060115 patent/WO2006087387A1/en active Application Filing
- 2006-02-20 ES ES06743193.2T patent/ES2533258T3/es active Active
- 2006-02-20 MX MX2007010051A patent/MX2007010051A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2006087387A1 (en) | 2006-08-24 |
EP1853567B1 (en) | 2014-12-31 |
CN101119976B (zh) | 2010-12-22 |
JP5247154B2 (ja) | 2013-07-24 |
US7935711B2 (en) | 2011-05-03 |
BRPI0607811B1 (pt) | 2019-08-20 |
RU2398768C2 (ru) | 2010-09-10 |
ES2533258T3 (es) | 2015-04-08 |
BRPI0607811B8 (pt) | 2021-05-25 |
AU2006215599B2 (en) | 2012-09-27 |
AU2006215599A1 (en) | 2006-08-24 |
EP1853567A1 (en) | 2007-11-14 |
JP2008530184A (ja) | 2008-08-07 |
MX2007010051A (es) | 2007-09-21 |
US20080194602A1 (en) | 2008-08-14 |
RU2007134564A (ru) | 2009-03-27 |
CN101119976A (zh) | 2008-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0607811A2 (pt) | derivados de óxido de pirimidina de 2-(4-cianofenilamino) inibidores de hiv, composição farmacêutica compreendendo os mesmo, processo para preparar a referida composição e uso | |
BRPI0607796A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparação e uso do mesmo, e, composição farmacêutica | |
BR0309012A (pt) | Uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para a preparação de um composto | |
BR0112224A (pt) | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto | |
BRPI0720220B8 (pt) | derivado de quinolina, sua composição farmacêutica, seu uso, seu processo de preparação, combinação e produto compreendendo o mesmo | |
BRPI0518459A2 (pt) | composto ou um sal farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, uso de um composto, e, processo para preparar o composto ou um sal farmaceuticamente aceitÁvel do mesmo | |
WO2007042786A3 (en) | 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors | |
BRPI0607214B8 (pt) | derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação | |
BR112018008397A2 (pt) | derivados de di-hidroimidazopirazinona úteis no tratamento do câncer | |
NO20081724L (no) | Stabil farmasoytisk sammensetning omfattende et pyrimidin-sulfamid | |
DOP2012000310A (es) | Morfolinopirimidinas y su uso en terapia | |
BR0314379A (pt) | Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase | |
AR055076A1 (es) | Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica. | |
BR112015014222A2 (pt) | composto, composição farmacêutica, uso de um composto, método para o tratamento de anemia e composição farmacêutica | |
BRPI0409498A (pt) | uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para preparação de um composto | |
BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
BR0308030A (pt) | Derivados de 5-feniltiazol e uso como inibidores de pi3 cinase | |
BRPI0512588A (pt) | derivados de uréia de pirimidina como inibidores de cinase | |
BRPI0510414A (pt) | uso de derivados de quinolina substituìdos para o tratamento de doenças micobacterianas resistentes a fármacos | |
BRPI0506760A (pt) | derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina como inibidores de igf-ir | |
AR054129A1 (es) | Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7 | |
CO2018005842A2 (es) | Composición farmacéutica que comprende un potente inhibidor de urat 1 | |
BRPI0412291A (pt) | antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia | |
BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
BRPI0706992C1 (pt) | composto de fórmula (i) e formulação farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: TIBOTEC PHARMACEUTICALS (IE) |
|
B25D | Requested change of name of applicant approved |
Owner name: JANSSEN R AND D IRELAND (IE) |
|
B25A | Requested transfer of rights approved |
Owner name: JANSSEN SCIENCES IRELAND UC (IE) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/08/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/08/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/02/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2710 DE 13-12-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |